Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vii) All inpatient clients, age at first use distribution by primary drug (%)

Substance	<15	15–19	20–24	25–29	30–34	35–39	40–44	45+	Mean age	Age known (base)	Age not known
Opiates	7.2	45.0	27.1	12.0	4.9	2.0	0.9	0.9	21.4	14014	1793
Cocaine	9.0	46.0	24.1	10.5	5.7	2.7	1.3	0.7	21.3	1887	391
Stimulants	19.5	58.7	14.2	3.7	1.8	0.9	0.5	0.5	18.6	3313	268
Hypnotics and sedatives	11.8	26.1	16.2	10.9	8.8	7.3	6.5	12.4	27.9	1168	317
Hallucinogens	13.0	44.4	22.2	16.7	1.9	1.9	0.0	0.0	20.4	54	20
Volatile substances	36.3	50.9	7.0	3.2	2.3	0.3	0.0	0.0	17.1	344	32
Cannabis	44.5	43.3	7.6	2.7	1.1	0.5	0.3	0.1	16.7	4091	528
Other substances	32.8	43.5	13.0	3.9	2.5	0.6	1.1	2.5	18.9	813	364
Total	16.3	45.8	20.9	8.9	4.0	1.9	1.0	1.2	20.5	25684	3713

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LU,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR. 

 Last data available from Poland refer to 2008. 

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Table TDI — inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)